These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24686566)

  • 1. Isolated cognitive relapses in multiple sclerosis.
    Pardini M; Uccelli A; Grafman J; Yaldizli Ö; Mancardi G; Roccatagliata L
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1035-7. PubMed ID: 24686566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecological impact of isolated cognitive relapses in MS.
    Meli R; Roccatagliata L; Capello E; Bruschi N; Uccelli A; Mancardi G; Inglese M; Pardini M
    Mult Scler; 2020 Jan; 26(1):114-117. PubMed ID: 30430928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
    Wilting J; Rolfsnes HO; Zimmermann H; Behrens M; Fleischer V; Zipp F; Gröger A
    Eur Radiol; 2016 Feb; 26(2):515-23. PubMed ID: 26026721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to detect cognitive dysfunction at early stages of multiple sclerosis?
    Deloire MS; Bonnet MC; Salort E; Arimone Y; Boudineau M; Petry KG; Brochet B
    Mult Scler; 2006 Aug; 12(4):445-52. PubMed ID: 16900758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
    Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
    J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study.
    Sundgren M; Piehl F; Wahlin Å; Brismar T
    Mult Scler Relat Disord; 2016 Nov; 10():36-43. PubMed ID: 27919496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
    Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP;
    J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study.
    Fenu G; Arru M; Lorefice L; Frau J; Coghe G; Fronza M; Loi L; Barracciu MA; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2018 Jul; 23():83-87. PubMed ID: 29800885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning and cognitive fatigue trajectories in multiple sclerosis defined using a burst measurement design.
    Holtzer R; Foley F; D'Orio V; Spat J; Shuman M; Wang C
    Mult Scler; 2013 Oct; 19(11):1518-25. PubMed ID: 23439579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    Moccia M; Lanzillo R; Costabile T; Russo C; Carotenuto A; Sasso G; Postiglione E; De Luca Picione C; Vastola M; Maniscalco GT; Palladino R; Brescia Morra V
    J Neurol; 2015; 262(4):961-7. PubMed ID: 25673130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).
    Greim B; Benecke R; Zettl UK
    J Neurol; 2007 May; 254 Suppl 2():II58-64. PubMed ID: 17503131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.